Sung-Kwon Moon

Title: **Innovative Contributions of Inventor Sung-Kwon Moon**

Introduction

Sung-Kwon Moon, an accomplished inventor based in Chungcheongbuk-do, South Korea, has made significant strides in the field of pharmaceuticals. With a singular yet impactful patent to his name, Moon's work showcases his dedication to advancing medical science and therapeutic options.

Latest Patents

Sung-Kwon Moon holds a patent for a novel pharmaceutical composition aimed at anti-angiogenesis. His invention revolves around a composition that utilizes neo-N-methylsansalvamide (NMSSV), a cyclic pentadepsipeptide, as an effective ingredient. The patent highlights its impressive capabilities to inhibit cell migration and tube formation associated with angiogenesis. Furthermore, the NMSSV has been shown to concentration-dependently block angiogenesis induced by vascular endothelial growth factor. This innovation holds promise as a therapeutic agent for a range of diseases characterized by abnormal angiogenesis.

Career Highlights

Moon is affiliated with the Chung Ang University Industry Academic Cooperation Foundation, a platform that fosters collaborations between academia and industry. His role at this institution emphasizes his commitment to bridging gaps in research and application, particularly in the pharmaceutical sector.

Collaborations

Throughout his career, Sung-Kwon Moon has collaborated with notable coworkers such as Chan Won Lee and Jee Taek Kim. These partnerships highlight the communal efforts in research and development, underscoring the importance of teamwork in advancing innovative solutions for health challenges.

Conclusion

Sung-Kwon Moon exemplifies the spirit of innovation in the field of pharmaceuticals. His patent on anti-angiogenic agents not only contributes to scientific knowledge but also paves the way for future therapeutic advancements. With continued collaboration and research, Moon's work may significantly impact the treatment of diseases affected by angiogenesis.